tiprankstipranks
Trending News
More News >
Aurobindo Pharma Ltd (IN:AUROPHARMA)
:AUROPHARMA
India Market
Advertisement

Aurobindo Pharma Ltd (AUROPHARMA) Income Statement

Compare
3 Followers

Aurobindo Pharma Ltd Income Statement

Last quarter (Q1 2026), Aurobindo Pharma Ltd's total revenue was ₹78.68B, an increase of 3.98% from the same quarter last year. In Q1, Aurobindo Pharma Ltd's net income was ₹8.25B. See Aurobindo Pharma Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 317.24B₹ 290.02B₹ 248.55B₹ 234.55B₹ 247.75B
Gross Profit
₹ 182.40B₹ 160.16B₹ 132.14B₹ 130.06B₹ 145.85B
Operating Expenses
₹ 62.39B₹ 55.66B₹ 51.09B₹ 52.00B₹ 51.82B
Depreciation and Amortization
₹ 14.49B₹ 13.73B₹ 11.23B₹ 10.05B₹ 9.41B
EBITDA
₹ 64.36B₹ 57.64B₹ 36.34B₹ 43.11B₹ 53.95B
Operating Income
₹ 120.01B₹ 104.50B₹ 81.05B₹ 78.06B₹ 94.03B
Other Income/Expenses
₹ -69.35B₹ -60.70B₹ -54.92B₹ -44.33B₹ -20.60B
Pretax Income
₹ 50.66B₹ 43.80B₹ 26.13B₹ 33.73B₹ 73.44B
Net Income
₹ 34.86B₹ 31.73B₹ 19.27B₹ 26.48B₹ 53.35B
Per Share Metrics
Basic EPS
₹ 59.81₹ 54.15₹ 32.90₹ 45.20₹ 91.05
Diluted EPS
₹ 59.81₹ 54.15₹ 32.90₹ 45.19₹ 91.05
Weighted Average Shares Outstanding
582.87M 585.94M 585.94M 586.00M 585.94M
Weighted Average Shares Outstanding (Diluted)
582.87M 585.94M 585.94M 585.94M 585.94M
Currency in INR

Aurobindo Pharma Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis